Page 68 - அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stubborn Gaps in Heart Failure Persist Despite Clinician Education, Feedback

email article An attempt to tie together the fragmented nature of heart failure (HF) care ultimately made no difference on clinical outcomes or care processes in the CONNECT-HF trial. U.S. centers randomized to a quality improvement intervention had patients with a cumulative incidence of a first HF rehospitalization or death approaching 40% at 1 year, similar to usual care (adjusted HR 0.92, 95% CI 0.81-1.05), reported Adam DeVore MD, MHS, of Duke University School of Medicine in Durham, North Carolina. Overall HF care quality too was indistinguishable between the intervention and control arms too. For example, intervention hospitals showed no meaningful improvements in getting more people on >50% target dosing of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and angiotensin receptor-neprilysin inhibition.

George washington university hospitalDistrict of columbiaUnited statesNorth carolinaDuke universityDipti itchhaporiaNicole louGurusher panjrathUniversity of californiaDuke university school of medicineAmerican college of cardiologyCentral michigan university in mount pleasantHoag heart vascular instituteAdam devoreDuke university schoolAmerican college

Therapeutic hypothermia below guidelines did not improve outcomes after cardiac arrest

In patients receiving therapeutic hypothermia after suffering out-of-hospital cardiac arrest, those who were cooled below 31 degrees Celsius (about 88 degrees Fahrenheit) for 24 hours showed no difference in terms of death or poor neurological outcomes at six months compared with patients receiving guideline-recommended cooling of 34 C (about 93 F). These findings are part of a study presented at the American College of Cardiology s 70th Annual Scientific Session.

Michelr leAmerican college of cardiologyUniversity of ottawa heart instituteAmerican collegeAnnual scientificOttawa heart instituteOttawa heartRandomized trial comparing mildMedicine healthClinical trialsஅமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல்பல்கலைக்கழகம் ஆஃப் ஆடவா இதயம் நிறுவனம்அமெரிக்கன் கல்லூரிஆண்டு அறிவியல்ஆடவா இதயம் நிறுவனம்ஆடவா இதயம்

HOST-EXAM: Clopidogrel Beats Aspirin as Monotherapy After Stenting

HOST-EXAM: Clopidogrel Beats Aspirin as Monotherapy After Stenting
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

United statesSoult ukpyolsiSouth koreaAnn arborSouth koreanHyo soo kimCindy grinesDeepak bhattDaiichi sankyoClaire duvernoySeoul national university hospitalAcademic research consortiumBoehringer ingelheimVascular centerUniversity of michiganCompanies chongkundang

ACC Survey: COVID Slams Already Weary CV Workforce

ACC Survey: COVID Slams Already Weary CV Workforce
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLong island jewish medical centerLaxmi mehtaShore university hospitalAmerican college of cardiologyOhio state universityTask force on clinicianAmerican collegeClinician well beingNorth americanNorth shore university hospitalபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்நீண்டது தீவு நகை மருத்துவ மையம்லக்ஷ்மி மேத்தா

Pacemaker Interference Warning; Religious Fasting and CVD; Toothpick in the Heart

email article FDA warned that implanted cardiac devices can go into magnet mode and stop working while they are held near cell phones, smartwatches, and other electronic devices. The Lancet) The American Heart Association and the American College of Cardiology (ACC) published updated guidance on maintaining ethics and professionalism in cardiovascular care. ( Circulation) Evinacumab (Evkeeza) reduced triglycerides in a small study of people with severe hypertriglyceridemia and a history of hospitalizations for acute pancreatitis. This benefit depended on genetic variants, however, according to the late-breaker at the virtual ACC meeting. VOYAGER PAD, also presented at ACC, showed that rivaroxaban (Xarelto) plus aspirin cut down on ischemic events after lower-extremity revascularization among patients with peripheral artery disease.

United statesNicole louPevinacumab evkeezaAmerican heart associationAmerican college of cardiologyAmerican collegeCardiovascular interventionsEuropean heart journalMedpage todayஒன்றுபட்டது மாநிலங்களில்நிக்கோல் லூஅமெரிக்கன் இதயம் சங்கம்அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல்அமெரிக்கன் கல்லூரிஇருதய தலையீடுகள்ஐரோப்பிய இதயம் இதழ்